It has a lot of good solid info about the company as well as the usual analyst WAGs and assumptions. The section on potential for acquisition was realistic and thoughtful, IMO.
Any worries about how long it has taken for the FDA to make a decision on approving NT pro-BNP test? I was expecting a decision by now, though the report indicated hearing news this year was expected.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.